291 related articles for article (PubMed ID: 15027317)
1. Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review.
Li Y; Zhang Y; Meng X; Chen S; Wang T; Zhang L; Ma X
Medicine (Baltimore); 2024 Jan; 103(3):e36728. PubMed ID: 38241589
[TBL] [Abstract][Full Text] [Related]
2. [The molecular-cytogenetic characterization and tyrosine kinase inhibitors efficacy in newly diagnosed chronic phase CML patients with variant Philadelphia chromosomes].
Zhao JJ; Zhang YL; Zhang SJ; Zhou J; Yu FK; Zu YL; Zhao HF; Li Z; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):212-218. PubMed ID: 29562466
[No Abstract] [Full Text] [Related]
3. [Philadelphia chromosome-negative myeloid neoplasms in patients with Philadelphia chromosome-positive chronic myeloid leukemia during tyrosine kinase inhibtor-therapy].
Yuan T; Wang XY; Lai YY; Qin YZ; Shi HX; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):547-553. PubMed ID: 32397016
[No Abstract] [Full Text] [Related]
4. Molecular monitoring in chronic myeloid leukemia: response to tyrosine kinase inhibitors and prognostic implications.
Jabbour E; Cortes JE; Kantarjian HM
Cancer; 2008 May; 112(10):2112-8. PubMed ID: 18348294
[TBL] [Abstract][Full Text] [Related]
5. Targeted treatment of chronic myeloid leukemia: role of imatinib.
Tamascar I; Ramanarayanan J
Onco Targets Ther; 2009 Feb; 2():63-71. PubMed ID: 20616895
[TBL] [Abstract][Full Text] [Related]
6. Chronic Myeloid Leukemia in a Patient with Hepatitis B Virus Infection: A Case Report.
Ali Hailan YM; Mudawi D; Yassin MA
Case Rep Oncol; 2021; 14(2):1004-1009. PubMed ID: 34326735
[TBL] [Abstract][Full Text] [Related]
7. The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.
Gallipoli P; Clark RE; Byrne J; Apperley JF; Milojkovic D; Foroni L; Goldman JM; O'Brien S
Br J Haematol; 2022 Mar; 196(6):e55-e57. PubMed ID: 34993961
[No Abstract] [Full Text] [Related]
8. Food for thought (and CML survival).
Sezaki M; Huang G
Blood; 2023 Aug; 142(6):502-504. PubMed ID: 37561542
[No Abstract] [Full Text] [Related]
9. Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patients.
Dilli Batcha JS; Gota V; Matcha S; Raju AP; Rao M; Udupa KS; Mallayasamy S
Cancer Chemother Pharmacol; 2024 Mar; ():. PubMed ID: 38441626
[TBL] [Abstract][Full Text] [Related]
10. Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia.
Janani G; Girigoswami A; Girigoswami K
ADMET DMPK; 2023; 11(4):499-511. PubMed ID: 37937247
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia.
Abdallah AM; Hafez H; Madney Y; Ahmed S; Yassin D; Salem S; Yousry R; Abdel-Azim H; Lehmann L; Elhaddad A
Leuk Lymphoma; 2024 Mar; ():1-4. PubMed ID: 38513148
[No Abstract] [Full Text] [Related]
12. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
13. New tyrosine kinase inhibitors in chronic myeloid leukemia.
Martinelli G; Soverini S; Rosti G; Cilloni D; Baccarani M
Haematologica; 2005 Apr; 90(4):534-41. PubMed ID: 15820950
[TBL] [Abstract][Full Text] [Related]
14. Specific targeted therapy of chronic myelogenous leukemia with imatinib.
Deininger MW; Druker BJ
Pharmacol Rev; 2003 Sep; 55(3):401-23. PubMed ID: 12869662
[TBL] [Abstract][Full Text] [Related]
15. Important therapeutic targets in chronic myelogenous leukemia.
Kantarjian HM; Giles F; Quintás-Cardama A; Cortes J
Clin Cancer Res; 2007 Feb; 13(4):1089-97. PubMed ID: 17317816
[TBL] [Abstract][Full Text] [Related]
16. [Imatinib therapy for patients with chronic myelogenous leukemia].
Usui N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):297-303. PubMed ID: 15791812
[TBL] [Abstract][Full Text] [Related]
17. [Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].
Usui N
Rinsho Byori; 2004 Feb; 52(2):136-44. PubMed ID: 15027317
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
